These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 29902387)
1. Role of ivabradine and heart rate lowering in chronic heart failure: guideline update. Chow SL; Page RL; Depre C Expert Rev Cardiovasc Ther; 2018 Jul; 16(7):515-526. PubMed ID: 29902387 [TBL] [Abstract][Full Text] [Related]
2. Advances in the management of heart failure: the role of ivabradine. Müller-Werdan U; Stöckl G; Werdan K Vasc Health Risk Manag; 2016; 12():453-470. PubMed ID: 27895488 [TBL] [Abstract][Full Text] [Related]
3. Ivabradine in Heart Failure: The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure. Das D; Savarese G; Dahlström U; Fu M; Howlett J; Ezekowitz JA; Lund LH Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28903983 [TBL] [Abstract][Full Text] [Related]
4. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction. Perry CM Am J Cardiovasc Drugs; 2012 Dec; 12(6):415-26. PubMed ID: 23181944 [TBL] [Abstract][Full Text] [Related]
5. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study. Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I; J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188 [TBL] [Abstract][Full Text] [Related]
6. Ivabradine: Current and Future Treatment of Heart Failure. Thorup L; Simonsen U; Grimm D; Hedegaard ER Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):89-97. PubMed ID: 28371247 [TBL] [Abstract][Full Text] [Related]
7. Ivabradine in Management of Heart Failure: a Critical Appraisal. Orasanu G; Al-Kindi SG; Oliveira GH Curr Heart Fail Rep; 2016 Feb; 13(1):60-9. PubMed ID: 26797824 [TBL] [Abstract][Full Text] [Related]
8. Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients. Rogers JK; Kielhorn A; Borer JS; Ford I; Pocock SJ Curr Med Res Opin; 2015; 31(10):1903-9. PubMed ID: 26361063 [TBL] [Abstract][Full Text] [Related]
9. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Fox K; Ford I; Steg PG; Tendera M; Ferrari R; Lancet; 2008 Sep; 372(9641):807-16. PubMed ID: 18757088 [TBL] [Abstract][Full Text] [Related]
10. Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials. Fox K; Komajda M; Ford I; Robertson M; Böhm M; Borer JS; Steg PG; Tavazzi L; Tendera M; Ferrari R; Swedberg K Eur Heart J; 2013 Aug; 34(29):2263-70. PubMed ID: 23536611 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety analysis of ivabradine hydrochloride treatment of Chinese patients with chronic heart failure: subgroup analysis of Chinese patients in the SHIFT study]. Hu DY; Huang DJ; Yuan ZY; Zhao RP; Yan XW; Wang MH; Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):190-197. PubMed ID: 28316174 [No Abstract] [Full Text] [Related]
12. Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease. Borer JS; Deedwania PC; Kim JB; Böhm M Am J Cardiol; 2016 Dec; 118(12):1948-1953. PubMed ID: 27780557 [TBL] [Abstract][Full Text] [Related]
13. Beta-blockers and ivabradine in chronic heart failure: from clinical trials to clinical practice. Di Franco A; Sarullo FM; Salerno Y; Figliozzi S; Parrinello R; Di Pasquale P; Lanza GA Am J Cardiovasc Drugs; 2014 Apr; 14(2):101-10. PubMed ID: 24327100 [TBL] [Abstract][Full Text] [Related]
14. An evaluation of the pharmacokinetics and pharmacodynamics of ivabradine for the treatment of heart failure. Rosa GM; Ferrero S; Ghione P; Valbusa A; Brunelli C Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):279-91. PubMed ID: 24377458 [TBL] [Abstract][Full Text] [Related]
15. Addition of ivabradine to β-blocker improves exercise capacity in systolic heart failure patients in a prospective, open-label study. Bagriy AE; Schukina EV; Samoilova OV; Pricolota OA; Malovichko SI; Pricolota AV; Bagriy EA Adv Ther; 2015 Feb; 32(2):108-19. PubMed ID: 25700807 [TBL] [Abstract][Full Text] [Related]
16. The Use and Indication of Ivabradine in Heart Failure. Dodd K; Lampert BC Heart Fail Clin; 2018 Oct; 14(4):493-500. PubMed ID: 30266358 [TBL] [Abstract][Full Text] [Related]
17. Is There a Role for Ivabradine in the Contemporary Management of Patients with Chronic Heart Failure in Academic and Community Heart Failure Clinics in Canada? Roth S; Fernando C; Azeem S; Moe GW Adv Ther; 2017 Jun; 34(6):1340-1348. PubMed ID: 28432646 [TBL] [Abstract][Full Text] [Related]